← Leaderboards
Atara Isaiah Ntekim
College Of Medicine, University Of Ibadan
$409,378
Attributed
$409,378
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $86K · FY2018–22$100K$75K$50K$25K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$409,378 · 1
By mechanism
K43$409,378 · 1
Top collaborators
No co-investigators on record.
Most similar at College Of Medicine, University Of Ibadan
Same institution · by research overlap
- Christian T. Happi$5,885,525
- David Olufemi Olaleye$8,127,823
- Lola Kola$796,553
- Isaac F Adewole$2,829,203
- Chimdi Chuka-Okosa$239,856
Others in their field
Other Emerging Leaders on “Chemotherapy-Oncologic Procedure”
- Carlos Castro-Gonzalez · Leuko Labs, Inc.$5,493,782
- Kord Michael Kober · University Of California, San Francisco$4,808,889
- Yi Ye · New York University$3,950,748
- Andrew R Haas · University Of Pennsylvania$3,721,334
- Victoria S Blinder · Sloan-Kettering Inst Can Research$3,601,187
- Hui-Ming Chang · University Of Missouri-Columbia$3,417,937
Research focus
Chemotherapy-Oncologic ProcedureCirculating MicrornaAftercareAfricanAdoptedAwardBaseBioinformaticsBiological MarkersAnticancer ResearchAntineoplastic AgentsBloodBlood TestsBreast Cancer DiagnosisBreast Cancer PatientCancer Clinical TrialCancer PatientCancer TherapyCarboplatinCareerCareer DevelopmentCaucasiansChemotherapyClinical Application
Grant awards (5)
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)$86,006
K43 · FY2022 · TW · contact PI
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)$85,449
K43 · FY2021 · TW · contact PI
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)$85,455
K43 · FY2020 · TW · contact PI
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)$78,343
K43 · FY2019 · TW · contact PI
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)$74,125
K43 · FY2018 · TW · contact PI